A detailed history of Avidian Wealth Solutions, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Avidian Wealth Solutions, LLC holds 12,201 shares of BMY stock, worth $648,971. This represents 0.02% of its overall portfolio holdings.

Number of Shares
12,201
Previous 6,369 91.57%
Holding current value
$648,971
Previous $345,000 46.67%
% of portfolio
0.02%
Previous 0.02%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$40.25 - $52.99 $234,738 - $309,037
5,832 Added 91.57%
12,201 $506,000
Q1 2024

May 03, 2024

BUY
$47.98 - $54.4 $17,032 - $19,312
355 Added 5.9%
6,369 $345,000
Q4 2023

Feb 06, 2024

SELL
$48.48 - $57.85 $90,269 - $107,716
-1,862 Reduced 23.64%
6,014 $308,000
Q3 2023

Oct 13, 2023

SELL
$57.89 - $64.73 $39,828 - $44,534
-688 Reduced 8.03%
7,876 $457,000
Q2 2023

Aug 03, 2023

SELL
$63.71 - $70.74 $28,159 - $31,267
-442 Reduced 4.91%
8,564 $547,000
Q1 2023

May 08, 2023

BUY
$65.71 - $74.53 $19,844 - $22,508
302 Added 3.47%
9,006 $624,000
Q4 2022

Feb 06, 2023

BUY
$68.48 - $81.09 $144,013 - $170,532
2,103 Added 31.86%
8,704 $626,000
Q3 2022

Nov 03, 2022

SELL
$0.13 - $76.84 $1,154 - $682,492
-8,882 Reduced 57.37%
6,601 $469,000
Q2 2022

Jul 29, 2022

BUY
$72.62 - $79.98 $56,716 - $62,464
781 Added 5.31%
15,483 $1.19 Million
Q1 2022

May 10, 2022

SELL
$61.48 - $73.72 $49,552 - $59,418
-806 Reduced 5.2%
14,702 $1.07 Million
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $1,555 - $1,813
-29 Reduced 0.19%
15,508 $967,000
Q3 2021

Nov 10, 2021

BUY
$59.17 - $69.31 $322,180 - $377,392
5,445 Added 53.95%
15,537 $919,000
Q2 2021

Aug 09, 2021

BUY
$61.91 - $67.42 $619 - $674
10 Added 0.1%
10,092 $674,000
Q1 2021

May 05, 2021

SELL
$59.34 - $66.74 $80,465 - $90,499
-1,356 Reduced 11.86%
10,082 $636,000
Q4 2020

Feb 09, 2021

BUY
$57.74 - $65.43 $12,587 - $14,263
218 Added 1.94%
11,438 $710,000
Q3 2020

Feb 03, 2021

BUY
$57.43 - $63.64 $644,364 - $714,040
11,220 New
11,220 $676,000
Q3 2020

Nov 06, 2020

SELL
$57.43 - $63.64 $647,293 - $717,286
-11,271 Closed
0 $0
Q2 2020

Aug 10, 2020

BUY
$54.82 - $64.09 $132,993 - $155,482
2,426 Added 27.43%
11,271 $663,000
Q1 2020

Apr 22, 2020

SELL
$46.4 - $67.43 $257,705 - $374,506
-5,554 Reduced 38.57%
8,845 $493,000
Q4 2019

Feb 13, 2020

SELL
$49.21 - $64.19 $139,608 - $182,107
-2,837 Reduced 16.46%
14,399 $924,000
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $131,047 - $155,375
3,064 Added 21.62%
17,236 $874,000
Q2 2019

Aug 14, 2019

BUY
$44.62 - $49.34 $7,496 - $8,289
168 Added 1.2%
14,172 $643,000
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $631,860 - $753,415
14,004 New
14,004 $668,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Avidian Wealth Solutions, LLC Portfolio

Follow Avidian Wealth Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidian Wealth Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avidian Wealth Solutions, LLC with notifications on news.